Medtronic receives FDA approval for the Integrity coronary stent


Mark Turco, director of cardiac and vascular research at Washington Adventist Hospital in Tacoma Park, USA, was among the first interventional cardiologists in the country to use the Integrity stent in clinical practice. “The Integrity stent system sets a new gold standard for deliverability thanks to the advance of continuous sinusoid technology. This new platform negotiates the twists and turns of the coronary anatomy remarkably well,” Turco said.

The company’s Driver bare metal and Endeavor drug-eluting stents are made from rings of a cobalt alloy that are shaped into crowns and, to maximise flexibility, laser fused where only certain points on the crowns meet. The Integrity stent is also made from cobalt alloy and is laser fused in a similar pattern. Instead of rings, continuous sinusoid technology enables each stent to be made from a single wire, comparable to a flexible spring. Like the Driver stent, the Integrity stent is also highly conformable.


The Integrity stent received the CE mark in February and is currently available in approximately 100 countries outside the United States.